Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unimedics is a leading South Korean medical device company specializing in the development and manufacture of advanced infusion systems and safety-oriented medical products. Founded in 1993, the company has established a significant global presence through its flagship Accufuser brand, which offers a range of high-precision, disposable infusion pumps used for chemotherapy, antibiotic delivery, and patient-controlled analgesia (PCA). In addition to infusion technology, Unimedics produces safety syringes and other medical disposables designed to prevent needle-stick injuries and enhance clinical safety for both patients and healthcare providers. The company operates a dedicated R&D center focused on bio-medical innovation and maintains a robust distribution network across Asia, Europe, and the Americas. Unimedics is recognized for its commitment to quality, holding international certifications such as CE, ISO 13485, and various regional regulatory clearances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unimedics.